Stock price when the opinion was issued
It was a good quarter. But it is important to note that one quarter does not make a trend, and there is still lots of work to be done here. It is still in turnaround mode. It still has a massive amount of debt. It is cheap, though, and the quarter might see shorts start to cover a bit. So the trend will likely be 'up' and the worst 'could' be over here. But there remains plenty of risk and we would prefer to see another quarter or two of continued improvement, and even pay more once the turn is indeed fully established and on a firm foothold. Much could still go wrong here.
Unlock Premium - Try 5i Free
Overall this is a decent company. For pharmacy companies in general, will some of the acquisition mode be curtailed under a Trump administration? A bit of a risk for this name. If you want to stay in this area, he would be inclined to move to CVS (CVS-N). Overall though this is a good name.